Study finds way to reduce COVID-19 deaths
Share - WeChat
Renmin Hospital of Wuhan University, a leading hospital in Wuhan, Hubei province, has reported a research finding that medicines containing statins have had a significant impact on reducing the death rate of COVID-19 patients.
Internationally renowned medical journal Cell Metabolism published the research results on Wednesday. It is another Chinese solution for the ongoing pandemic.
The research is based on 13,983 confirmed cases of COVID-19 in 21 hospitals around Hubei province.
The death rate could be lowered from 9.4 percent for patients who have not taken statins to 5.2 percent for those who have taken them.
- China starts construction of water diversion project to quench thirst of metropolis
- China's Greater Bay Area builds world-class city cluster through connectivity, innovation
- Guangzhou forestry and fruit expo to showcase Xinjiang's specialty products
- Xi's special envoy to attend inauguration of Bolivia's president
- Tianjin's Hangu Salt Field marks 1,100th anniversary
- Explainer: What does China's 2035 per capita GDP goal of 'mid-level developed country' status mean






























